Christine Dierks
Ernst Grube Str. 40
Halle, NI 06120, Germany
Halle, NI 06120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in aggressive thyroid cancer.
Journal: Journal of translational medicine
Published: August 22, 2025
Comparing definitions of SARS-CoV-2 infection in a prospective household transmission study.
Journal: Journal of infection and public health
Published: July 09, 2025
VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML.
Journal: Annals of hematology
Published: April 20, 2025
Case Report: Influence of BRCA1 germline mutation on treatment-related morbidity of a non-seminomatous germ cell tumor patient.
Journal: Frontiers in oncology
Published: February 19, 2025
JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL.
Journal: The Journal of experimental medicine
Published: April 21, 2023
Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients.
Journal: Blood cancer journal
Published: December 02, 2021
Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21R110 chronic lymphocytic leukemia.
Journal: Blood cancer journal
Published: November 02, 2021
Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).
Journal: Langenbeck's archives of surgery
Published: March 29, 2021
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: March 02, 2021
T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10.
Journal: Nature communications
Published: February 26, 2021
Last Updated: 09/26/2026